Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-26T07:04:23.699Z Has data issue: false hasContentIssue false

42 - Drugs for managing cancer pain

Published online by Cambridge University Press:  04 August 2010

Barry A. Eagel
Affiliation:
Beth Israel Medical Center, New York
Michael J. Fisch
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Eduardo Bruera
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Get access

Summary

Assessment of the severity and causes of pain dictate the type of drugs used for treatment. The choice of drugs and route of administration is dependent on

  1. The severity of the pain.

  2. The frequency and duration of the pain.

  3. The source or cause of the pain.

Drugs used to treat pain can be broadly divided into analgesics and adjuvant drugs. Adjuvant drugs are not considered analgesics (per se), however, they can augment the analgesic properties of analgesics for specific pain syndromes, for instance corticosteroids for spinal cord compression or antidepressants for neuropathic pain. In addition, adjuvant drugs include those which can be used to manage undesirable but expected adverse effects of analgesics.

The goal of pain management is to achieve the best possible pain relief with the least side effects. Choices of drugs, doses, and routes should be tailored to meet these goals for the individual patient.

The WHO three-step ladder is useful for establishing the class of drug to start with depending on the severity of the pain at initial assessment, or if there is a failure to achieve adequate pain control with less potent drugs.

Step 1. Analgesics for mild pain include aspirin, acetaminophen and NSAIDs. These drugs have a ceiling effect (beyond a certain dose range, increasing the dose does not provide for greater analgesic effect), and have specific organ toxicities at high doses. Acetaminophen is the only drug in this group which has no antiplatelet activity, which may be important postsurgery and in patients with thrombocytopenia or thrombopathy.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bruera, E, Pereira, J, Watanabe, S, Belzile, M, Kuehn, N, Hanson, J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 1996;78:852–73.0.CO;2-T>CrossRefGoogle Scholar
Bruera, E, Belzile, M, Pituskin, E. Randomized, double-blind, cross-over trial comparing the safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 1998;16:3222–9CrossRefGoogle ScholarPubMed
Cleeland, C S, Gonin, R, Hatfield, A K. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592–6CrossRefGoogle ScholarPubMed
Mercadante, S, Casuccio, A, Agnello, A, Serretta, R, Calderone, L, Barresi, L. Morphine versus methadone in the pain treatment of advanced cancer patients followed up at home. J Clin Oncol. 1998;16:3656–61CrossRefGoogle ScholarPubMed
Ripamonti, C, Groff, L, Brunelli, C, Polastri, D, Stavrakis, A, Conno, F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?J Clin Oncol 1998;16:3216–21CrossRefGoogle ScholarPubMed
Cherney, N I, Arbit, E, Jain, S. Invasive techniques in the management of cancer pain. Hematol Oncol Clin N Am 1996;10:121–37CrossRefGoogle Scholar
Cherney, N, Ripamonti, C, Pereira, J, Davis, C, Fallon, M, McQuay, H. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542–54CrossRefGoogle Scholar
Indelicato, R A, Portenoy, R K. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2002;20:348–52CrossRefGoogle ScholarPubMed
Pereira, J, Lawlor, P, Vigano, A, Dorgan, M, Bruera, E. Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;22:672–7CrossRefGoogle ScholarPubMed
Portenoy, R K. Issues in the economic analysis of therapies for cancer pain. Oncology 1995;9 (Suppl.):71–8Google ScholarPubMed
Portenoy R, Frager G. Pain management: pharmacological approaches. In Palliative Case and Rehabilitation of Cancer Patients, ed. C F Gunter. Boston: Kluwer Academic, 1999
Portenoy, R K, Hagen, N A. Breakthrough pain: definition and management. Oncology 1989; 3 (Suppl.):25–9Google ScholarPubMed
Rowlingson, J C. Interventional cancer pain management. Anesthes Analges 1998; Suppl.:106–13Google Scholar
CancerNet – NCI Cancer Supportive Care guidelines www.cancer.gov/cancerinfo/pdg/supportivecare
Agency for Healthcare Research and Quality (AHRQ) Management of Cancer Pain. Evidence Report/Technology Assessment http://www.ahrq.gov/clinic/canpainsum.htm
Edmonton Palliative Care Program http://www.palliative.org/pc\_home.html
M. D. Anderson Cancer Center Pain Management http://www.mdanderson.org/topics/paincontrol/
Beth Israel Medical Center, Dept of Pain Medicine and Palliative Care http://www.stoppain.org/
American Pain Society http://www.ampainsoc.org/
International Association for the Study of Pain http://www.iasp-pain.org
University of Wisconsin Pain and Policy Studies Group http://www.medsch.wisc.edu/painpolicy/
American Academy of Pain Medicine http://www.painmed.org/
American Pain Foundation http://www.painfoundation.org/
University of Washington Hypermedia Assistant for Cancer Pain Management Website (including AHCPR Cancer Pain Guidelines) http://www.talaria.org/
NIH State-of-the-Science Statement on Cancer Pain, Depression, Fatigue http://www.consensus.nih.gov/ta/022/022\_statement.htm
Bruera, E, Pereira, J, Watanabe, S, Belzile, M, Kuehn, N, Hanson, J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 1996;78:852–73.0.CO;2-T>CrossRefGoogle Scholar
Bruera, E, Belzile, M, Pituskin, E. Randomized, double-blind, cross-over trial comparing the safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 1998;16:3222–9CrossRefGoogle ScholarPubMed
Cleeland, C S, Gonin, R, Hatfield, A K. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592–6CrossRefGoogle ScholarPubMed
Mercadante, S, Casuccio, A, Agnello, A, Serretta, R, Calderone, L, Barresi, L. Morphine versus methadone in the pain treatment of advanced cancer patients followed up at home. J Clin Oncol. 1998;16:3656–61CrossRefGoogle ScholarPubMed
Ripamonti, C, Groff, L, Brunelli, C, Polastri, D, Stavrakis, A, Conno, F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?J Clin Oncol 1998;16:3216–21CrossRefGoogle ScholarPubMed
Cherney, N I, Arbit, E, Jain, S. Invasive techniques in the management of cancer pain. Hematol Oncol Clin N Am 1996;10:121–37CrossRefGoogle Scholar
Cherney, N, Ripamonti, C, Pereira, J, Davis, C, Fallon, M, McQuay, H. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542–54CrossRefGoogle Scholar
Indelicato, R A, Portenoy, R K. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2002;20:348–52CrossRefGoogle ScholarPubMed
Pereira, J, Lawlor, P, Vigano, A, Dorgan, M, Bruera, E. Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;22:672–7CrossRefGoogle ScholarPubMed
Portenoy, R K. Issues in the economic analysis of therapies for cancer pain. Oncology 1995;9 (Suppl.):71–8Google ScholarPubMed
Portenoy R, Frager G. Pain management: pharmacological approaches. In Palliative Case and Rehabilitation of Cancer Patients, ed. C F Gunter. Boston: Kluwer Academic, 1999
Portenoy, R K, Hagen, N A. Breakthrough pain: definition and management. Oncology 1989; 3 (Suppl.):25–9Google ScholarPubMed
Rowlingson, J C. Interventional cancer pain management. Anesthes Analges 1998; Suppl.:106–13Google Scholar
CancerNet – NCI Cancer Supportive Care guidelines www.cancer.gov/cancerinfo/pdg/supportivecare
Agency for Healthcare Research and Quality (AHRQ) Management of Cancer Pain. Evidence Report/Technology Assessment http://www.ahrq.gov/clinic/canpainsum.htm
Edmonton Palliative Care Program http://www.palliative.org/pc\_home.html
M. D. Anderson Cancer Center Pain Management http://www.mdanderson.org/topics/paincontrol/
Beth Israel Medical Center, Dept of Pain Medicine and Palliative Care http://www.stoppain.org/
American Pain Society http://www.ampainsoc.org/
International Association for the Study of Pain http://www.iasp-pain.org
University of Wisconsin Pain and Policy Studies Group http://www.medsch.wisc.edu/painpolicy/
American Academy of Pain Medicine http://www.painmed.org/
American Pain Foundation http://www.painfoundation.org/
University of Washington Hypermedia Assistant for Cancer Pain Management Website (including AHCPR Cancer Pain Guidelines) http://www.talaria.org/
NIH State-of-the-Science Statement on Cancer Pain, Depression, Fatigue http://www.consensus.nih.gov/ta/022/022\_statement.htm

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×